Lipella Pharmaceuticals LIPO
LIPO
$0.00 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Lipella Pharmaceuticals Inc. (LIPO) Price to Sales (2022 - 2025)

Updated

Lipella Pharmaceuticals' (LIPO) Price to Sales was 7.11 for Q3 2025, down 24.7% from 9.45 a year earlier and down 16.8% from the prior quarter.

Analysis

Lipella Pharmaceuticals Inc. (LIPO) Price to Sales (2022 - 2025) Analysis & Trends

For FY2024, Price to Sales at Lipella Pharmaceuticals was 6.87, down 49.9% from FY2023.

  • By year, Price to Sales came in at 13.73 in FY2023 (-80.1%) and 69.02 in FY2022.
  • Five-year quarterly Price to Sales spans a low of 6.87 in Q4 2024 and a high of 69.02 in Q4 2022.
  • Year over year, Price to Sales gained in 1 of the last eight quarters, with an average decline of 42.9%.
  • The high point for year-over-year Price to Sales in five years was Q2 2025 (growth of 20.4%); the low point was Q4 2023 (a decline of 80.1%).
  • Per Business Quant data, the three quarters before Q3 2025 came in at 8.55 (Q2 2025), 9.93 (Q1 2025) and 6.87 (Q4 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 7.11
Jun 30, 2025 8.55
Mar 31, 2025 9.93
Dec 31, 2024 6.87
Sep 30, 2024 9.45
Jun 30, 2024 7.10
Mar 31, 2024 10.91
Dec 31, 2023 13.73
Sep 30, 2023 18.15
Jun 30, 2023 32.72
Mar 31, 2023 41.63
Dec 31, 2022 69.02
API Access

Lipella Pharmaceuticals Inc. Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=LIPO&period=max&api_key=YOUR_API_KEY